Non-pancreatic periampullary adenocarcinomas: An explanation for favorable prognosis

Hepato-Gastroenterology

Volumn 51, Issue 57, 2004, Pages 842-846

  Katz, Matthew H G ^a   Bouvet, Michael ^a   Al Refaie, Waddah ^a   Gilpin, Elizabeth A ^a   Moosa, A R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Pancreas; Pancreatic cancer; Pancreatico duodenectomy; Periampullary adenocarcinoma

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; BILIARY TRACT SURGERY; CANCER INVASION; CANCER SURGERY; DUODENUM; FEMALE; HISTOPATHOLOGY; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; PANCREAS RESECTION; PANCREAS TUMOR; PERIAMPULLARY ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SMALL INTESTINE RESECTION; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; VATER PAPILLA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 2342512845     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Bouvet M, Binmoeller KF, Moossa AR: Diagnosis of adenocarcinoma of the pancreas. In: Cameron JL (Ed.). American Cancer Society Atlas of Clinical Oncology: Pancreatic Cancer. Hamilton, Ontario: BC Decker, 2001.
2. Halstead W: Contributions to the surgery of the bile passages, especially of the common bile duct. Boston Med Surg J 1899; 141:645-654.
3. Jemal A, Thomas A, Murray T, Thun M: Cancer statistics, 2002. CA Cancer J Clin 2002; 52:23-47.
4. Bouvet M, Gamagami RA, Gilpin EA, Romeo O, Sasson A, Easter DW, Moossa AR: Factors influencing survival after resection for periampullary neoplasms. Am J Surg 2000; 180:13-17.
5. Geer RJ, Brennan MF: Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993; 165:68-72; discussion 72-63.
6. Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemce KD, Pitt HA: Periampullary adenocarcinoma: analysis of 6-year survivors. Ann Surg 1998; 227:821-831.
7. Moossa AR, Scott MH, Lavelle-Jones M: The place of total and extended total pancreatectomy in pancreatic cancer. World J Surg 1984; 8:895-899.
8. Sener SF, Fremgen A, Menck HR, Winchester DP: Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 1999; 189:1-7.
9. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, Dooley WC, Coleman J, Pitt HA: Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995; 221:721-731; discussion 731-723.
10. Nitecki SS, Sarr MG, Colby TV, van Heerden JA: Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995; 221:59-66.
11. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA; Sauter PK, Coleman J, Hruban RH, Lillemoe KD: Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4:567-579.
12. Howe JR, Klimstra DS, Moccia RD, Conlon KC, Brennan MF: Factors predictive of survival in ampullary carcinoma. Ann Surg 1998; 228:87-94.
13. Esposito I, Friess H, Buchler MW: Carcinogeneais of cancer of the papilla and ampulla: pathophysiological facts and molecular biological mechanisms. Langenbecks Arch Surg 2001; 386:163171.
14. Sarmiento JM, Nagomey DM, Sarr MG, Farnell MB: Periampullary cancers: are there differences? Surg Clin North Am 2001; 81:543-555.
15. Zhu L, Kim K, Domenico DR, Appert HE, Howard JM: Adenocarcinoma of duodenum and ampulla of Vater: clinicopathology study and expression of p53, c-neu, TGF-alpha, CEA, and EMA. J Surg Oncol 1996; 61:100-105.
16. Bortolasi L, Burgart LJ, Tsiotos GG, Luque-De Leon E, Sarr MG: Adenocarcinoma of the distal bile duct. A clinicopathologic outcome analysis after curative resection. Dig Surg 2000; 17:36-41.
17. Argani P, Shaukat A, Kaushal M, Wilentz RE, Su GH, Sohn TA, Yeo CJ, Cameron JL, Kern SE, Hruban RH: Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. Cancer 2001; 91:1332-1341.
18. Michelassi F, Erroi F, Dawson PJ, Pietrabissa A, Noda S, Handcock M, Block GE: Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Ann Surg 1989; 210:544-554; discussion 554-546.
19. Shyr YM, Su CH, Wang HC, Lo SS, Lui WY: Comparison of resectable and unresectable periampullary carcinomas. J Am Coll Surg 1994; 178:369-378.